International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8178950
Original Article
A Comparative Study to Evaluate the Effect of Thermal Cycling on the Flexural Strength of Bis-Acryl Composite Resin, Light Cure Resin and Cad/Cam Resin for Provisional Restorations-An In Vitro Study
 ,
 ,
Published
July 24, 2023
Abstract

Aim: To compare the effect of thermal cycling on the flexural strength of Bis -acryl composite resin, light cure UDMA resin and CAD/CAM  PMMA resin for provisional restorations.

Materials And Methods: This study included 60 specimens. Twenty bar-shaped specimens were fabricated for each group Bis-Acryl composite resin, Light cure UDMA Resin and CAD/CAM Resin with the use of a split acrylic mold. These specimens were stored in artificial saliva for 10 days. The specimens were then subjected to thermal cycling. Flexural strength was calculated using three point bending test under universal testing machine. Data were analyzed using student-ttest (α=0.05) @ 90% power.

Results: The highest mean and standard deviation before thermal cycling was seen in CAD/CAM Resin (106.74 ± 3.61 ) and the lowest in Bis-Acryl composite Resin (92.57± 1.36). The highest mean and standard deviation after thermal cycling was seen in CAD/CAM(94.83± 2.56) and the lowest in Bis-Acryl Composite Resin (81.34 ± 1.64).

Conclusion: Within the limitations of this study by analyzing the results, it was concluded that the Thermal cycling had shown significant impact on the flexural strength of all the materials. Group A Specimens (CAD/CAM PMMA Resin) exhibited highest flexural strength before and after thermal cycling followed by Group C Specimens (Bis- Acryl Composite Resin ) and Group B (UDMA Resin group ).

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
52 Views
167 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved